ResMed | RMD - Loan Capital


ResMed reported $399.42M in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
Ansell USD 751.6M 113.1M Dec/2025
Artivion USD 363.42M 148.07M Jun/2026
AtriCure USD 61M 0 Jun/2026
Baxter International USD 8.62B 6M Jun/2026
Cochlear AUD 200M 6.5M Dec/2025
Cooper Companies USD 1.92B 54.8M Jun/2026
CSL USD 10.42B 273M Dec/2025
Dexcom USD 1.3B 200K Jun/2026
Edwards Lifesciences USD 598.7M 1.3M Jun/2026
Fisher Paykel Healthcare NZD 113.3M 50.7M Jun/2026
Globus Medical USD 398K 38K Mar/2026
Haemonetics USD 1.17B 50.36M Jun/2026
Idexx Laboratories USD 299.86M 11K Jun/2026
Inogen USD 0 0 Jun/2022
Insulet USD 929.5M 0 Jun/2026
Integra LifeSciences USD 1.83B 2.05M Jun/2026
Intuitive Surgical USD 0 0 Mar/2025
Medtronic USD 25.62B 502M Jun/2026
Philips EUR 6.32B 575M Jun/2026
Ramsay Health Care AUD 11.2B 5.74B Dec/2025
ResMed USD 399.42M 4.75M Jun/2026
Sigma Healthcare AUD 1.88B 1.75B Dec/2025
Sonic Healthcare AUD 4.19B 333.39M Dec/2024
Steris USD 1.65B 162.6M Jun/2026
Teleflex USD 2.72B 206.24M Jun/2026
Thermo Fisher Scientific USD 39.18B 890M Jun/2026